Global Centrifugal Blood Pump Market Size, Share, By Type (Electronic Centrifugal Blood Pump and Mechanical Centrifugal Blood Pump), By Application (Short Term Support and Long Term Support), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2026 - 2035.

Global Centrifugal Blood Pump Market Insights Forecasts to 2035

• The Global Centrifugal Blood Pump Market Size Was Estimated at USD 25.92 Billion in 2025
• The Market Size is Expected to Grow at a CAGR of around 10.18% from 2026 to 2035
• The Worldwide Centrifugal Blood Pump Market Size is Expected to Reach USD 68.36 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

 

Get more details on this report -

Request Free Sample PDF

According to a research report published by Spherical Insights and Consulting, the global centrifugal blood pump market size was worth around USD 25.92 billion in 2025 and is predicted to grow to around USD 68.36 billion by 2035 with a compound annual growth rate (CAGR) of 10.18% from 2026 to 2035. Global innovations like magnetic levitation, which reduces blood damage and improves durability, improved biocompatible materials, optimized flow systems, smart monitoring and AI-based optimization are all driving opportunities in the centrifugal blood pump market. 

 

Market Overview

The centrifugal blood pump market refers to the global industry which develops, produces and sells mechanical pumps which use centrifugal force for blood circulation during medical procedures that include cardiac surgery, extracorporeal membrane oxygenation and ventricular assist support. The system consists of devices, controllers, cannulae, and other accessories which hospitals, ambulatory surgical centers, and specialty clinics use. Rising cardiovascular diseases, increasing need for minimally invasive procedures, and technological advancements which include magnetically levitated pumps and smart monitoring systems that enhance efficiency and patient safety create market opportunities. The expanding healthcare infrastructure in emerging economies and the rising use of portable systems create fresh opportunities for market development.

 

Through the support of research and development, medical device approval process, healthcare infrastructure funding and awareness program promotion, governments create a system which drives innovation while maintaining safety standards and helps centrifugal blood pump technologies achieve broader market acceptance globally. For instance, in November 2025, the Medical Device Parks scheme of India obtained funding of INR 87111 crore which it used to develop facilities in Greater Noida Ujjain and Kanchipuram, to establish advanced device manufacturing facilities and decrease need for imported products, which would strengthen the centrifugal blood pump industry.

 

In January 2024, the U.S. FDA approved the CentriMag Acute Circulatory Support System which established its safety as well as its authorization to enter the market for extracorporeal blood circulation support devices regulates centrifugal blood pumps used in ECMO and cardiac surgery through its 510(k) clearance system.

 

Report Coverage

This research report categorizes the centrifugal blood pump market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the centrifugal blood pump market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the centrifugal blood pump market.  

 

Driving Factors

Rapid technological innovation is one of the main drivers of the centrifugal blood pump market's growth. Rising prevalence of cardiovascular diseases and increasing demand for advanced cardiac care procedures such as ECMO and heart surgeries, which is the main factor driving the market for centrifugal blood pump. In this field, innovation and investment are driven by the rising demand for minimally invasive procedures and technological progress through magnetic levitation and smart monitoring systems results in improved operational efficiency and enhanced patient safety. The market expansion benefits from developing healthcare facilities in emerging markets and rising healthcare expenditure. Additionally, an aging population, higher use of portable and durable devices, government support, and increased public knowledge about early diagnosis and treatment further propel the market growth.

 

In 2025, the U.S. FDA approved centrifugal blood pump systems through the 510(k) pathway which included the Quantum Perfusion CP20/CP22 system that received its first approval on June 24, 2025 under K250326 and its second approval on August 4, 2025 under K251762. The approval allows these systems to be utilized in cardiopulmonary bypass and ECMO procedures throughout the United States.

 

Restraining Factors

High development and deployment costs, strict regulatory approval processes, risks associated with device use, limited reimbursement policies in some countries, the need for skilled professionals, and concerns over long-term reliability and maintenance are the main factors restricting the centrifugal blood pump market.

 

Market Segmentation

The centrifugal blood pump market share is classified into type, application, and end user.  

 

• The electronic centrifugal blood pump segment dominated the market in 2025, approximately 65%, and is projected to grow at a substantial CAGR during the forecast period.

Based on the type, the centrifugal blood pump market is divided into electronic centrifugal blood pump and mechanical centrifugal blood pump. Among these, the electronic centrifugal blood pump segment dominated the market in 2025, approximately 65%, and is projected to grow at a substantial CAGR during the forecast period. Provides precise flow control, real-time monitoring, and enhanced safety mechanisms that reduce the risk of complication, minimizes mechanical friction, and improves durability and efficiency is driving the electronic centrifugal blood pump industry.

 

• The short term support segment accounted for the largest share in 2025, approximately 70%, and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the centrifugal blood pump market is divided into short term support and long term support. Among these, the short term support segment accounted for the largest share in 2025, approximately 70%, and is anticipated to grow at a significant CAGR during the forecast period. Widespread use in cardiac surgeries and ECMO, cost-effective, easier to manage, and associated with lower long-term complication risks, and provides high volume of acute care cases and emergency interventions is driving the short term support industry.

 

• The hospitals segment accounted for the highest market revenue in 2025, approximately 70%, and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end user, the centrifugal blood pump market is divided into hospitals, ambulatory surgical centers, specialty clinics, and others. Among these, the hospitals segment accounted for the highest market revenue in 2025, approximately 70%, and is anticipated to grow at a significant CAGR during the forecast period. Primary settings for complex procedures, equipped with sophisticated infrastructure, intensive care units, and skilled healthcare professionals, higher patient inflow, better reimbursement facilities, and the availability of advanced technologies is bolstering hospitals market. 

 

Get more details on this report -

Request Free Sample PDF

 

Regional Segment Analysis of the Centrifugal Blood Pump Market

• North America (U.S., Canada, Mexico)
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America)
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the centrifugal blood pump market over the predicted timeframe.

North America is anticipated to hold the largest share of the centrifugal blood pump market over the predicted timeframe. Strong government backing advanced medical facilities and major medical device companies operate in the region are what propel North America. The region's position is further reinforced by government programs promoting magnetically levitated pumps and AI-based monitoring systems to enhance surgical accuracy and patient health results. The need for medical services increases because of high number of heart-related health disorders. The market expansion receives support from advantageous reimbursement systems, high healthcare spending, and active research development initiatives. The presence of dedicated cardiac treatment centers together with trained medical staff members enables North America to maintain its leading position in centrifugal blood pump market.

 

Get more details on this report -

Request Free Sample PDF

 

Government initiatives include Canada’s CIHR Funding, 2023 supports innovation in cardiac assist devices and extracorporeal circulation technologies, indirect support for centrifugal blood pumps and the U.S. NHLBI Pediatric Circulatory Support Program supporting development of next-generation pediatric blood pumps and ECMO systems, including miniaturized centrifugal blood pump technologies.

 

Asia Pacific is expected to grow at a rapid CAGR in the centrifugal blood pump market during the forecast period. China, Japan, and South Korea are among the nations experience rising heart disease cases among their population base drive regional growth. The demand for sophisticated centrifugal blood pump is further accelerated by the region's advanced cardiac treatment accessibility, medical tourism growth and government hospital modernization support drives faster medical technology adoption. Asia Pacific has emerged as the most active regional market because its manufacturing costs are low and medical device companies are expanding their operations throughout the area.

 

Government launches include China’s NMPA approved a centrifugal pump-based ECMO system on 23 February 2023 for emergency clinical use, enabling faster access to life-support devices and Japan’s PMDA under MHLW approves centrifugal pump-based ECMO and cardiac support devices ensuring safe hospital use.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the centrifugal blood pump market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Medtronic plc
• Abbott Laboratories
• Terumo Corporation
• Getinge AB
• LivaNova PLC
• XENIOS AG
• Braile Biomedica Ltd.
• Qura Srl
• Senko Medical Instrument Mfg. Co. Ltd.
• Eurosets S.r.l.
• Baxter International Inc.
• Spectrum Medical
• BiVACOR Inc.
• Jarvik Heart, Inc.
• Hugo Sachs Elektronik
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)
• Value-Added Resellers (VARs)

 

Recent Development

• In November 2025, Getinge achieved ongoing expansion by developing its extracorporeal circulation and perfusion systems which include Rotaflow centrifugal pump-based ECMO platforms that enhance patient outcomes and operational efficiency.

 

• In November 2025, Terumo developed its cardiovascular and ECMO technologies through the introduction of centrifugal pump systems which function in sophisticated cardiac surgical operations and medical support treatments.

 

• In January 2025, Abbott demonstrated its ongoing progress through its cardiac support portfolio which included centrifugal blood pump-based ECMO systems that operate under its heart failure business unit, leading to worldwide medical adoption.

 

• In April 2024, Abbott announced updates and expanded clinical use for its CentriMag Acute Circulatory Support System, which operates as a centrifugal blood pump system for ECMO and cardiac support, thus enhancing its functionality as a short-term mechanical circulatory support solution.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the centrifugal blood pump market based on the below-mentioned segments: 

 

Global Centrifugal Blood Pump Market, By Type

• Electronic Centrifugal Blood Pump
• Mechanical Centrifugal Blood Pump

 

Global Centrifugal Blood Pump Market, By Application

• Short Term Support
• Long Term Support

 

Global Centrifugal Blood Pump Market, By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

 

Global Centrifugal Blood Pump Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa